Andrew G. McKee

Andrew G. McKee

Auto-generated profile, based on publicly available information

Andrew G. McKee

Department of Chemistry, Indiana University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
WPWesley D. Penn
Wesley D. Penn
AMAndrew G. McKee
Andrew G. McKee
CKCharles P. Kuntz
Charles P. Kuntz
HWHope Woods
Hope Woods
VNVeronica Nash
Veronica Nash
JSJonathan P. Schlebach
Jonathan P. Schlebach
Sequence constraints associated with topological energetics restrict the evolution and mutational tolerance of membrane proteins.

11 December 2025 in eLife
Verified
Journal Article
Open access
ATAustin Tedman
Austin Tedman
JOJohn A Olson
John A Olson
MKMinsoo Kim
Minsoo Kim
CFCatherine Foye
Catherine Foye
JJJaNise J Jackson
JaNise J Jackson
JSJonathan P Schlebach
Jonathan P Schlebach
Cystic fibrosis (CF) is a genetic disease caused by mutations in the cystic fibrosis transmembrane conductance regulator gene ( CFTR ). Though most people with CF have one or two copies of the ΔF508 mutation, there are hundreds of other distinct CF mutations that vary in their mechanistic effects and response to therapeutics. Endogenous chaperones are known to have divergent effects on the druggability of CF variants. Nevertheless, it remains unclear how this proteostatic modulation is related to the underlying mechanistic effects of distinct classes of CF mutations. Here, we survey the effects of a previously discovered effector (calnexin, CANX) on the expression and pharmacological rescue of 232 CF variants using deep mutational scanning. We find that CANX is generally required for robust plasma membrane expression of the CFTR protein, particularly for CF variants that perturb its second nucleotide-binding domain. CANX also appears to be critical for the pharmacological rescue of CF variants with poor basal expression. Though corrector selectivity is generally dictated by the properties of mutations, we find that CANX enhances the sensitivity of CF variants within a domain-swapped region of membranes spanning domain 2 to the type III corrector VX-445. Overall, mutagenic trends suggest CANX modulates the later stages of CFTR assembly and disproportionately affects variants bearing mutations within the C-terminal domains. Interestingly, we find that the loss of CANX results in widespread perturbations of CF variant interactomes and that the proteostatic effects of CANX are generally decoupled from changes in CFTR activity. Together, our findings reveal how the proteostasis machinery may shape the variant-specific effects of corrector molecules.

30 July 2024 in eLife
Verified
Journal Article
Open access
LCLaura M Chamness
Laura M Chamness
CKCharles P Kuntz
Charles P Kuntz
AMAndrew G McKee
Andrew G McKee
WPWesley D Penn
Wesley D Penn
CHChristopher M Hemmerich
Christopher M Hemmerich
JSJonathan P Schlebach
Jonathan P Schlebach
Many membrane proteins are prone to misfolding, which compromises their functional expression at the plasma membrane. This is particularly true for the mammalian gonadotropin-releasing hormone receptor GPCRs (GnRHR). We recently demonstrated that evolutionary GnRHR modifications appear to have coincided with adaptive changes in cotranslational folding efficiency. Though protein stability is known to shape evolution, it is unclear how cotranslational folding constraints modulate the synergistic, epistatic interactions between mutations. We therefore compared the pairwise interactions formed by mutations that disrupt the membrane topology (V276T) or tertiary structure (W107A) of GnRHR. Using deep mutational scanning, we evaluated how the plasma membrane expression of these variants is modified by hundreds of secondary mutations. An analysis of 251 mutants in three genetic backgrounds reveals that V276T and W107A form distinct epistatic interactions that depend on both the severity and the mechanism of destabilization. V276T forms predominantly negative epistatic interactions with destabilizing mutations in soluble loops. In contrast, W107A forms positive interactions with mutations in both loops and transmembrane domains that reflect the diminishing impacts of the destabilizing mutations in variants that are already unstable. These findings reveal how epistasis is remodeled by conformational defects in membrane proteins and in unstable proteins more generally.